Free public education event on neuromodulation therapies to be held at Vancouver Convention Centre

Unlocking the potential of neuromodulation: Leading experts and patients share insights at public education event in Vancouver

2024-04-09

(Press-News.org) Vancouver, BC – The Canadian Neuromodulation Society and the International Neuromodulation Society (INS) are delighted to announce a public education event, "Understanding Neuromodulation of the Brain and Spinal Cord”.

This complimentary event is scheduled to take place at the Vancouver Convention Centre, East Building, on Saturday, May 11, from 13:30 to 18:00, during the 16th INS World Congress.

Aimed at patients, their families, and friends dealing with conditions such as chronic pain, Parkinson’s disease, and tremor, this event is also open to interested members of the public, media representatives, and professionals.

This gathering comprises several lectures that pair scientifically and clinically substantiated insights with firsthand, real-world experiences. It provides a unique opportunity to learn directly from both local and international medical experts and patients about neuromodulation therapies. Neuromodulation treatments involve “altering nerve activity through the targeted delivery of electrical stimulation or chemical agents to specific neurological sites in the body” (Source: INS).

This event will be moderated by Dr. Christopher Honey, MD, DPhil, FRCPC, FACS, Professor & Head, Division of Neurosurgery at the University of British Columbia, as well as esteemed leader, clinician, author and INS Congress Chair.

"I am both delighted and honoured to chair this meeting. We have brought the world's experts in neuromodulation and more than a thousand clinicians to Vancouver for the scientific meeting. The public lectures will provide background information on neuromodulation and allow our patients to give a first-hand review of their experience with the technology."

Event Highlights:

Educational Sessions: A series of talks covering various aspects of neuromodulation, including its application for Parkinson’s Disease, tremor, dystonia, back & leg pain, neuropathic pain (CRPS and post-surgical), and angina and peripheral vascular disease. Patient Experiences: Hear firsthand accounts from patients who have benefited from neuromodulation therapies, providing insights into their journeys and outcomes. Interactive Q&A: Dedicated Q&A sessions will allow attendees to engage with experts, ask questions, and deepen their understanding of neuromodulation and its risks and benefits. Networking: Opportunities for attendees to connect with healthcare professionals, researchers and others interested in neuromodulation. This event is particularly significant as it precedes the INS 16th World Congress on Neuromodulation, highlighting the importance of public education alongside scientific discourse. It underlines the commitment of both the Canadian Neuromodulation Society and INS to raising awareness about therapies that can significantly improve the quality of life for individuals with chronic conditions.

Registration Information:

Attendance is free of charge, but registration is required. Interested participants are encouraged to register early to secure their place at this informative session.

About the International Neuromodulation Society:

The International Neuromodulation Society (INS) is a global non-profit organization focused on the scientific development and awareness of neuromodulation. The INS is dedicated to promoting improved patient care through education, research, and advocacy in the field of neuromodulation. The Canadian Neuromodulation Society has been an established chapter of the INS since 2006.

Contact:

For more information about the event and to register, please visit the INS Congress Public Education Event website. For media inquiries, contact Mandi Soleil at ins@neuromodulation.com.

END

ELSE PRESS RELEASES FROM THIS DATE:

SwRI demonstrating robotics for in-space manufacturing at Space Symposium

2024-04-09

SAN ANTONIO — April 9, 2024 — Southwest Research Institute has invested in new space robotics capabilities to help the space industry pave the way for in-space servicing, assembly and manufacturing (ISAM) capabilities. SwRI’s Intelligent Systems Division will demonstrate new ISAM-focused research at the 38th Space Symposium, April 8-11, in Colorado Springs. Visit SwRI at Booth #237. “SwRI is developing solutions to leverage Earth-based industrial robotics with advanced automation and simulation so we can help clients develop new capabilities for the complex conditions ...

Cleveland Clinic, Tufts University research ties gut microbial TMAO pathway to chronic kidney disease

2024-04-09

April 9, 2024, Cleveland: New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time. The findings build on more than a decade of research spearheaded by Stanley Hazen, M.D., Ph.D., and a team related to the gut microbiome’s role in cardiovascular health and disease, including the adverse effects of TMAO, a byproduct formed by the gut bacteria from nutrients abundant in red meat, eggs and other animal source foods. The study, published in the Journal of the American Society of Nephrology, was a collaboration ...

Ochsner Health utilizes groundbreaking ablation system for atrial fibrillation

2024-04-09

New Orleans, LA – Ochsner Health is proud to bring an advancement in the treatment of heart rhythm disorders to the New Orleans and Gulf South region utilizing a new cardiac ablation procedure, the FARAPULSE™ Pulsed Field Ablation System. The innovative procedure was performed at the John Ochsner Heart & Vascular Institute, a frontrunner in cardiology that continues to set the standard for cardiovascular care through its commitment to pioneering breakthrough therapies. With the estimated number of individuals affected by atrial fibrillation predicted to rise to 12.1 million in the United States by 2030 according to the CDC, the introduction of this new treatment ...

Brigham researchers develop SCENT for genetic mapping of autoimmune diseases

2024-04-09

Genetic studies of diseases map segments of the genome driving disease. But to understand how those changes contribute to disease progression, it is important to understand how they may alter gene regulation of disease genes in cell populations assumed to be driving disease. “Enhancer-gene maps” link genomic regulatory regions to genes and are essential for understanding disease. But constructing them poses challenges due to limitations in current experimental methods, that make it difficult to apply the technique to rare cell populations and genes that ...

Cognitive decline may be detected using network analysis, according to Concordia researchers

2024-04-09

We all lose our car keys or our glasses from time to time. Most people would be correct to laugh it off as a normal part of aging. But for others, cognitive decline may start as a worrying but clinically unnoticeable step toward cognitive impairment, be it relatively mild or as severe as Alzheimer’s disease. The vast complexity of the human brain makes early diagnosis of cognitive decline difficult to achieve, which has potentially important implications for treatment and prevention. This is especially true ...

Clinical trial finds nasal spray safely treats recurrent abnormal heart rhythms

2024-04-09

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms. The study, published March 25 in the Journal of the American College of Cardiology, provides real-world evidence that a wide range of patients can safely and effectively use the experimental drug, called etripamil, to treat recurrent paroxysmal supraventricular ...

FAU lands $1.3 million grant to ‘clean up’ stinky seaweed in Florida

2024-04-09

In the last decade, the emergence of a massive expanse of Sargassum, the Great Atlantic Sargassum Belt, has wreaked havoc on ecosystems and economies throughout the Caribbean. Conversely, this stinky brown seaweed provides vital habitats for marine life including loggerhead sea turtles. One of the worst invasions of Sargassum in recent history, especially for Florida, occurred in 2022 and potential impacts this year are yet to be determined. Decomposing Sargassum produces hydrogen sulfide and ammonia, which can result in potential human and environmental health impacts. Once Sargassum deluges beaches, removing, disposing and repurposing the seaweed presents many logistical ...

Breeding more resilient soybeans may come down to test site selection

2024-04-09

URBANA, Ill. — In the quest to optimize crop productivity across environments, soybean breeders test new cultivars in multiple locations each year. The best-performing cultivars across these locations are selected for further breeding and eventual commercialization. However, a new study from the University of Illinois Urbana-Champaign suggests current soybean testing locations may not be delivering breeders the biggest bang for their buck. “We met with most of the soybean breeders in public research universities across the Midwest and asked where they set up their trials over the last 30 to 40 years,” said Nicolas Martin, ...

Morphine tolerance results from Tiam1-mediated maladaptive plasticity in spinal neurons

2024-04-09

BIRMINGHAM, Ala. – Morphine and other opioids are vital to treat severe and chronic pain. However, they have two problems — prolonged use creates morphine tolerance, where ever-increasing doses are needed for the same pain relief, and paradoxically, prolonged use also can create an extreme sensitivity to pain, called hyperalgesia. Researchers at the University of Alabama at Birmingham and Baylor College of Medicine, Houston, Texas, now have shown that blocking the activity of an enzyme called Tiam1 in certain ...

USC-led study leverages artificial intelligence to predict risk of bedsores in hospitalized patients

2024-04-09

Bedsores—also known as pressure injuries—are the fastest rising hospital-acquired condition, according to the U.S. Agency for Healthcare Research in Quality, and as a result have become the second most common reason for medical malpractice suits in the United States. Although most hospital-acquired pressure injuries are reasonably preventable, approximately 2.5 million individuals in the United States develop a pressure injury in acute care facilities every year, and 60,000 die. The total annual cost for U.S. health systems to manage the acute needs of patients’ ...

Free public education event on neuromodulation therapies to be held at Vancouver Convention Centre

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: